Perspectives on Peripheral Neuropathy as a Consequence of Metformin-Induced Vitamin B12 Deficiency in T2DM
- PMID: 28932240
- PMCID: PMC5591993
- DOI: 10.1155/2017/2452853
Perspectives on Peripheral Neuropathy as a Consequence of Metformin-Induced Vitamin B12 Deficiency in T2DM
Abstract
Peripheral neuropathy (PN) is a primary complication of type 2 diabetes mellitus (T2DM) and a direct manifestation of vitamin B12 deficiency. Examining the effects of metformin use on PN status became imperative following clinical studies that showed the vitamin B12-lowering effect of the medication. The complexity of the topic and the inconsistency of the results warrant consideration of topic-specific perspectives for better understanding of the available evidence and more appropriate design of future studies.
References
-
- Candrilli S. D., Davis K. L., Kan H. J., Lucero M. A., Rousculp M. D. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Journal of Diabetes and Its Complications. 2007;21(5):306–314. - PubMed
-
- Gordois A., Scuffham P., Shearer A., Oglesby A., Tobian J. A. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–1795. - PubMed
-
- Ting R. Z., Szeto C. C., Chan M. H., Ma K. K., Chow K. M. Risk factors of vitamin B12 deficiency in patients receiving metformin. Archives of Internal Medicine. 2006;166(18):1975–1979. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
